In the interim prior to licensure of these new small molecule inhibitors, established therapy with pegylated interferon and ribavirin can be tailored.

• 在这些新型小分子抑制剂获得临床使用许可前，我们可以对业已形成的聚乙二醇化干扰素联合病毒唑的治疗方案进行适当的修改。